Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Breast Cancer Metastatic × Tamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 34 Neoplasms 7 Neoplasm Metastasis 2 Sarcoma 1 Quality of Life 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Subjects 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Bone Density 1 Advanced Metastatic Breast Cancer 1 Advanced Cancer 1

Interventions

Trastuzumab 2 Gemcitabine 2 Docetaxel 2 tusamitamab ravtansine 1 nirogacestat 1 margetuximab 1 exemestane 1 Vinorelbine 1 Tamoxifen 1 Letrozole 1 Fulvestrant 1 Capecitabine 1 Anastrozole 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04059484 2026-02-24

AMEERA-3

Sanofi

Phase 2 Terminated

367 enrolled 30 charts

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡